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Abstract
The Pax6 gene plays crucial roles in eye development and encodes a transcription factor containing both a paired domain and a
homeodomain. During embryogenesis, Pax6 is expressed in restricted tissues under the direction of distinct cis-regulatory regions. The head
surface ectoderm-specific enhancer of mouse Pax6 directs reporter expression in the derivatives of the ectoderm in the eye, such as lens and
cornea, but the molecular mechanism of its control remains largely unknown. We identified a Pax6 protein-responsive element termed LE9
(52 bp in length) within the head surface ectoderm-specific enhancer. LE9, a sequence well conserved across vertebrates, acted as a highly
effective enhancer in reporter analyses. Pax6 protein formed in vitro a complex with the distal half of LE9 in a manner dependent on the
paired domain. The proximal half of the LE9 sequence contains three plausible sites of HMG domain recognition, and HMG domain-
containing transcription factors Sox2 and Sox3 activated LE9 synergistically with Pax6. A scanning mutagenesis experiment indicated that
the central site is most important among the three presumptive HMG domain recognition sites. Furthermore, Pax6 and Sox2 proteins formed
a complex when they were expressed together. Based on these findings, we propose a model in which Pax6 protein directly and positively
regulates its own gene expression, and Sox2 and Sox3 proteins interact with Pax6 protein, resulting in modification of the transcriptional
activation by Pax6 protein.
© 2003 Elsevier Science (USA). All rights reserved.
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Introduction
Pax6 encodes a member of the Pax family transcription
factors and has been identified as a key regulator gene of
eye development in both vertebrates and invertebrates
(Walther et al., 1991; Halder et al., 1995). During vertebrate
development, the Pax6 gene is expressed in the eye, the
central nervous system, some of the sensory placodes, and
the pancreas (Grindley et al., 1995; Callaerts et al., 1997;
Mansouri et al., 1999). Transgenic studies in mice using the
lacZ reporter gene identified, in the upstream regulatory
region of the mouse Pax6 gene, a modular structure of the
enhancers responsible for various expression domains (Wil-
liams et al., 1998; Kammandel et al., 1999; Xu et al., 1999);
four distinct enhancer regions have been identified thus far
for the pancreas, the head surface ectoderm, the telenceph-
alon, and the retina, respectively. The head surface ecto-
derm-specific enhancer directs the reporter gene expression
in a spatiotemporal pattern similar to that of the endogenous
Pax6 expression in the derivatives of the head surface ec-
toderm in the eye, i.e., the developing lens, cornea, con-
junctiva, and lacrimal gland (Kammandel et al., 1999; Wil-
liams et al., 1998). In particular, the central 102-bp region of
the enhancer has been found essential for the lens-specific
expression of the reporter gene (Kammandel et al., 1999).
The sequence of the enhancer is highly conserved among
vertebrates, and disruption of the enhancer causes abnor-
malities in lens development (Dimanlig et al., 2001).
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Pax6 plays essential roles in lens development, and its
expression level has critical effects on this process. Studies
of Pax6 overexpression (Schedl et al., 1996; Chow et al.,
1999) and analyses of haploinsufficiency of the Small eye
(Sey) mutant mouse, which carries a mutation in the Pax6
gene (Hogan et al., 1988; Hill et al., 1991; van Raamsdonk
and Tilghman, 2000), have provided evidence that altered
levels of Pax6 expression result in defects in lens develop-
ment. The endogenous Pax6 transcript is initially detected
in a broad area of the head surface ectoderm at earlier stages
than the emergence of the lens placode. Later, the expres-
sion is more concentrated in the lens placode and the lens
vesicle, and is also detected in the surface ectoderm over the
lens vesicle, which gives rise to the cornea and the conjunc-
tiva (Li et al., 1994; Grindley et al., 1995). The mechanism
of control of the level of Pax6 expression in the developing
lens is largely unknown, but is considered to be complex
and multistep. It was demonstrated by studies of the level of
expression of the Pax6 transcript in Sey/Sey mouse embryos
that Pax6 autoregulates its own expression in the presump-
tive lens ectoderm (Grindley et al., 1995). It was uncertain,
however, whether this autoregulation was mediated in a
cell-autonomous, or in a non-cell-autonomous fashion,
since normal lens development is critically dependent on the
tissue interaction between the prospective lens ectoderm
and the optic vesicle, where the Pax6 gene is also expressed.
Recently, a study of conditional gene disruption of mouse
Pax6 in the prospective lens ectoderm revealed that Pax6
protein itself is required in the ectoderm for sustained Pax6
gene transcription (Ashery-Padan et al., 2000). These in
vivo studies provided evidence that Pax6 protein is cell-
autonomously required for its own gene expression in the
developing lens, but the molecular basis for the Pax6 auto-
regulation is not yet fully understood.
In this study, we attempted to elucidate the mechanism of
control of Pax6 gene expression by examining the head
surface ectoderm-specific enhancer of the mouse Pax6 gene.
We found that the enhancer is activated by Pax6 and Sox
proteins in reporter assays, and that Pax6 alone exhibits
substantial activation of the enhancer. We identified a Pax6-
responsive element within this enhancer region. Our results
suggest that Pax6 protein directly recognizes this element
via the paired domain and interacts with Sox2 and Sox3
proteins to synergistically activate the enhancer element.
Based on the present results, we propose a model in which
the Pax6 gene directly regulates its own expression in the
lens region during development.
Materials and methods
Cell culture
SRA01/04 human lens epithelial cells were established
and maintained as previously described (Ibaraki et al.,
1998). NMuMG mouse mammary gland epithelial cells and
RL-34 rat liver epithelial cells were obtained from Ameri-
can Type Culture Collection and Science Research Re-
sources Bank, Japan, respectively, and maintained in Dul-
becco’s Modified Eagle Medium (DMEM) supplemented
with 10% heat-inactivated fetal calf serum.
Construction of reporter and effector plasmids
Construction of the control plasmid pRL-1PGK, which
carries the constitutive promoter of the mouse Pgk-1 gene
(Boer et al., 1990) and the Renilla luciferase cDNA, and the
reporter plasmid pE4luc, which contains the adenovirus E4
promoter and the firefly luciferase cDNA, were described
previously (Kitamura et al., 2000). The Pax6 P0 promoter
was obtained by PCR using oligonucleotides 197(GC-
ACTCGAGGCAACCAATGAGGGCATT) and 156(ACC-
AAGCTTGACAACCGGGTTCTACGCGAGGA) as PCR
primers, and mouse genomic DNA as template. The 129-bp
fragment was inserted between the XhoI–HindIII sites of
pGL3-basic plasmid (Promega), and the resulting plasmid
was termed pP0luc. The mouse Pax6 head surface ecto-
derm-specific enhancer region (Williams et al., 1998; Ka-
mmandel et al., 1999) was also cloned by PCR. For making
reporter plasmids, various fragments of the enhancer region
were cloned between the SacI and XhoI sites of pE4luc and
pP0luc. The position of each enhancer fragment was as
follows: LE4, from the 1st to 526th base sequence of Gen-
Bank entry MMPAXP1 (Accession No. AF098639); LE4d,
1–173 and 305–526; LE3, 1–341; LE1, 166–341; LE2,
166–309; LE6, 166–244; LE7, 196–309; LE8, 236–309;
LE12, 175–244; LE9, 166–217; LE10, 188–217; LE11,
166–195; LE0, 166–309.
As controls, we also constructed pPRD and pPRDx4
reporter plasmids, which carry an “optimal” binding se-
quence of the Pax6 paired domain (CATTTTCACGCAT-
GAGTGCACA; Epstein et al., 1994a) at the XhoI site of
pE4luc. The latter plasmid contains four repeats of this
binding sequence. All constructs were verified by DNA
sequencing.
A cDNA clone encoding human Pax6 isoform b (also
called Pax6-5a) was obtained from the IMAGE consortium
EST project (Lennon et al., 1996). The extra exon 5a of
Pax6b was removed by means of site-directed mutagenesis,
and the resultant fragments were inserted in a constitutive
expression vector, pactEF (Okazaki and Sagata, 1995). The
entire coding regions of mouse cDNAs for Sox2 and Sox3
were also similarly cloned in pactEF.
DNA transfection
For transfection of cells seeded in a 12-well plate, 80 ng
of pRL-1PGK and 270 ng of each firefly luciferase reporter
were combined with various amounts of effector plasmids.
Control plasmid pactEF was included to make the total
amount of DNA 500 ng. Fugene 6 transfection reagent
(Roche, 1.25 l) was added to each DNA mixture in 60 l
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of DMEM. After 30 min of incubation at room temperature,
the DNA–Fugene complex was added to each well. After
24 h, firefly and Renilla luciferase activities in the cell lysate
were measured by using a luminometer equipped with two
injectors for the Dual-luciferase assay reagents (Promega).
Relative luciferase activity was calculated by dividing the
level of firefly luciferase activity by the level of Renilla
luciferase activity. DNA was independently prepared at
least twice, and the assay for each reporter construct was
repeated four times.
Electrophoretic mobility shift assay (EMSA)
Oligonucleotides were synthesized based on the se-
quences of the enhancer fragments. An extra “CG” dinucle-
otide sequence was attached at the 5 end of each oligonu-
cleotide sequence for 3 fill-in labeling with [-32P]dCTP
by the Klenow fragment of Escherichia coli DNA polymer-
ase I. For in vitro synthesis of Pax6 and Pax6b, cDNA
fragments cloned in pT7G plasmid (Oe et al., 2001) were
linearized and incubated in a phage T7 RNA polymerase-
coupled reticulocyte lysate system (Promega) according to
the manufacturer’s instructions.
Nuclear extracts were prepared as follows. NMuMG
cells were transfected with the Pax6 expression plasmid (12
g) and Fugene 6 (24 l) in 9-cm-diameter dishes. After
24 h, the cells were washed twice with ice-cold PBS and
then with hypotonic buffer (10 mM Tris–HCl, pH 7.4, 1.5
mM MgCl2, 10 mM KCl). The cells were lysed in 1 ml of
cell-lysis buffer (10 mM Tris–HCl, pH 7.4 at 25°C, 1.5 mM
MgCl2, 10 mM KCl, 0.5 mM PMSF, 7 mM 2-ME, 0.1%
NP-40) on ice, and the total cell lysate was collected by
scraping into a 1.5-ml centrifuge tube. Cell nuclei were
obtained by centrifugation at 800g for 2 min at 4°C, and
then incubated in extraction buffer (10 mM Tris–HCl, pH
7.4 at 25°C, 20 % glycerol, 340 mM NaCl, 1.5 mM MgCl2,
0.2 mM EDTA, 0.5 mM PMSF, 0.1% 2-ME) for 40 min on
ice. Nuclear extracts were prepared by centrifuging the
mixture at 12,000g for 15 min at 4°C.
For EMSA, the nuclear extracts were diluted about 30-
fold (to 20 g/ml protein concentration) with dilution buffer
(20 mM Hepes–KOH, pH 7.9, 100 mM KCl, 0.2 mM
EDTA, 20% glycerol, 0.1% NP-40, 7 mM 2-ME, 0.5 mg/ml
BSA, 0.5 mM PMSF). Labeled probe (5000 cpm, about 2–5
 1015 mol) was mixed with 1 l of the diluted extract, 5
l of 2 binding buffer (40 mM Hepes–KOH buffer, pH
7.9, 30% glycerol, 200 mM KCl, 14 mM 2-ME), and 0.5 g
(unless otherwise noted) of poly(dI–dC) (Amersham-Phar-
macia) in a total volume of 10 l, and incubated at room
temperature for 30 min. For super-shift analysis, 1 g of
monoclonal antibody for Pax6 protein or nonimmune IgG
was included. Electrophoresis was performed by using 6%
acrylamide gels and 0.5 TBE buffer.
For the EMSA for Sox2 binding, recombinant proteins
containing the HMG domain of Sox2 (amino acid residues
1–130) or the paired domain of Pax6 (1–136) was purified
by using the GST system (Amersham-Pharmacia). Labeled
probe was mixed with 1 l of diluted recombinant proteins
in the dilution buffer supplemented with 0.2 mg/ml BSA
(see above) and 5 l of 2 binding buffer in a total volume
of 10 l.
Immunoprecipitation and immunoblotting
Pax6- and Sox2-coding sequences were N-terminally
tagged with Flag and Myc epitope tags, respectively.
Transfection of 293T cells and preparation of the cell
lysate under nondenaturing conditions were previously de-
scribed (Kitamura et al., 2000; Okazaki and Sagata, 1995).
Immunoprecipitation was carried out by using anti-Flag M2
antibody (KODAK) or anti-Myc 9E10 antibody (1 g each)
and 30 l of immobilized protein A beads (Pierce) for each
cell lysate (300 g of protein), and half of the immunopre-
cipitated proteins were used for SDS–PAGE. After SDS–
PAGE, the proteins were immunoblotted by using the anti-
Flag or anti-Myc antibody as previously described
(Kitamura et al., 2000). HRP-linked anti-mouse -light
chain was used as the secondary antibody.
Results
Identification and mapping of a Pax6-responsive element
in the head surface ectoderm-specific enhancer of the
Pax6 gene
To assess activation by Pax6 protein, we first transfected
SRA01/04 human lens epithelial cells with luciferase re-
porter plasmids carrying different portions of the head sur-
face ectoderm-specific enhancer region of the mouse Pax6
gene (Fig. 1A and B) together with various amounts of the
Pax6-expression vector (Fig. 1C). Among the tested DNA
fragments, LE0 corresponds to the minimal lens-specific
enhancer region determined in a transgenic study (Kam-
mandel et al., 1999). We also prepared the PRD reporter
construct, which contains an “optimal” binding sequence of
the Pax6 paired domain (Epstein et al., 1994a), as a control.
As shown in Fig. 2A, several enhancer fragments, such
as LE9 and LE6, responded to Pax6 protein in a dose-
dependent manner. When epithelial cells derived from tis-
sues other than the lens were used, Pax6 coexpression also
activated reporter constructs carrying the LE9 sequence
(Fig. 2B for RL-34 rat liver epithelial cells; similar data
obtained with NMuMG mouse mammary gland epithelial
cells are not shown), indicating that this activation by Pax6
protein occurred in various cell types. Although SR01/04
cells retain some characteristics of lens epithelial cells
(Ibaraki et al., 1998), the expression level of Pax6 in
SR01/04 cells was below the limit of detection of Western
blotting (data not shown) using an anti-Pax6 monoclonal
antibody (Kawakami et al., 1997).
In these reporter assays, Pax6 protein only weakly acti-
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vated reporter plasmids containing a single copy of PRD or
LE11 (a subregion of LE9; Fig. 1). The reporter plasmid
with the LE11 sequence in the reverse orientation (LE11R),
however, appeared to respond to Pax6 (Fig. 2C). Among the
reporter constructs with four repeats of enhancer fragments,
PRDx4 and LE11x4, but not LE10x4, was activated by
Pax6 in RL-34 cells (Fig. 2D). Similar results were obtained
with other types of cells (data not shown). LE9 consistently
showed Pax6-responsiveness in either orientation. Taken
together, these results indicate that the LE9 fragment of the
head surface ectoderm-specific enhancer region acts as a
transcriptional enhancer when sufficient levels of Pax6 pro-
tein are present in various cell types, including lens cells.
The distal half of LE9 (LE11) exhibited Pax6-response in
some reporter constructs, suggesting that this part of LE9 is
important for Pax6-responsiveness. Interestingly, LE6 and
LE9 responded to Pax6 better than longer fragments, such
as LE3 and LE4, that included the whole LE9 region (Fig. 1).
This result suggests that there may be negative regulatory
elements within the enhancer sequence but outside of LE9.
The mouse Pax6 gene has three distinct promoter re-
gions, P0, P1, and P (Kammandel et al., 1999), and an in
situ hybridization study using exon-specific probes indi-
cated that the P0-initiated transcripts are prominently ex-
pressed in the lens region during mouse development (Xu et
al., 1999). Furthermore, the sequence of the P0 promoter
region is highly conserved between mouse and quail. It has
been reported that quail Pax6 protein can bind to its own P0
promoter, although the isolated P0 promoter alone is not
sufficient to induce a cell type-specific response in a re-
porter assay (Plaza et al., 1993). We therefore examined a
mouse Pax6 P0 promoter fragment which contains the re-
gion corresponding to the quail Pax6-binding candidate site.
Reporter assays using the adenovirus E4 promoter and the
mouse Pax6 P0 promoter showed similar responses to Pax6
protein (Fig. 2E). The effect of LE9 on transcriptional
activation was much larger than the difference of activity
between these two promoters. For simplicity, we describe
only the results of reporter assays using constructs with the
E4 promoter in the following experiments.
We next examined the Pax6b (also called Pax6-5a) iso-
form which contains 14 extra amino acid residues derived
from alternative splicing in its paired domain. In sharp
contrast to Pax6, Pax6b coexpression resulted in no notable
activation of the LE9 reporter (Fig. 2F). Since the insert in
the Pax6b paired domain causes alteration of the DNA
binding specificity (Epstein et al., 1994b; Kozmik et al.,
1997), our results strongly suggest that the paired domain of
Pax6 is involved in the activation of LE9 and LE11 by Pax6
protein.
Fig. 1. Mapping a Pax6 protein-responsive site upstream of the mouse Pax6 gene. (A) A schematic diagram of a series of partially overlapping DNA
fragments that encompass the head surface ectoderm-specific enhancer region of the mouse Pax6 gene. The head surface ectoderm-specific enhancer region,
LE4, has a sequence highly conserved between human and mouse (Williams et al., 1998). LE0, indicated by an open box, corresponds to the minimal region
for the lens-specific enhancer activity determined in a transgenic mouse study (Kammandel et al., 1999). The region found to have full activity in the present
study (LE9) is shaded in gray for easy comparison of the positions of the fragments. (B) The structures of the transcription reporter plasmids. Each enhancer
fragment was inserted into the reporter vectors with the coding sequence for firefly luciferase and either the adenovirus E4 promoter or the mouse Pax6 P0
promoter. (C) The expression vectors for Pax6 and Sox proteins. Coding sequences for Pax6, Pax6b, Sox2, and Sox3 were driven by a constitutive promoter
in pactEF expression vector. The regions encoding the paired domain and the homeodomain of Pax6 are shown as black and gray boxes, respectively. The
cDNA for Pax6b contains an insertion (shown by a white box) derived from alternatively spliced exon 5a in the paired domain. The HMG domains of Sox2
and Sox3 are indicated by hatched boxes.
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Pax6 forms a complex with the distal half of LE9
To examine the physical interaction between the Pax6-
responsive element and Pax6 protein, we performed EMSA
using 32P-labeled LE9 and LE11 probes (Fig. 3A). As
shown in Fig. 3B, nuclear extract prepared from NMuMG
cells transfected with the Pax6 expression construct mark-
edly shifted the LE11 probe. Similar results were obtained
with the LE9 probe, which includes the LE11 sequence
(data not shown). When an anti-Pax6 monoclonal antibody
(Kawakami et al., 1997) was added to the incubation mix-
ture, a super-shift band appeared (Fig. 3B, lane 10). These
Fig. 2. LE9 acts as a minimum Pax6-responsive element. (A) Transcriptional activation of enhancer fragments in cultured lens cells. SRA01/04 lens epithelial
cells were transfected with reporter plasmid containing the indicated fragment together with increasing amounts of Pax6 expression vector, pactEF-Pax6 (0,
75, or 150 ng; white, hatched, and black columns, respectively). Relative luciferase activities are shown as the average and standard deviation from four
separate experiments. The activity of the basal reporter (pE4luc) in the absence of Pax6 expression vector was taken as 1. We also included an “optimal”
binding sequence for the Pax6 paired domain as a control (PRD). These reporter plasmids utilize the adenovirus E4 promoter. The scores of Student’s t test
of LE9 and LE11 induction by Pax6 against the basal construct were P  0.001 and P  0.23, respectively, the latter of which was not significant. (B)
Pax6-responsive enhancer activity in RL-34 cells. RL-34 liver epithelial cells were transfected and the luciferase activities were assayed as in (A). (C) LE11
was inserted in the reverse orientation (LE11R) and assayed in RL-34 cells. Activities are shown as fold-induction, which was calculated by dividing the level
of the relative luciferase activity in the presence of Pax6 expression vector pactEF-Pax6 (150 ng) by that in the absence of the Pax6 expression vector. (D)
Pax6-response of repeated enhancer sequences. LE9, LE10, or LE11 sequences were tandemly repeated four times, and inserted into the basal pE41uc reporter
plasmid. “R” denotes the reverse orientation. Activities obtained with RL-34 cells are shown in fold-induction. (E) LE9 confers responsiveness to Pax6
protein on the Pax6 P0 promoter and on the viral E4 promoter to a similar extent. The relative luciferase activity of the basal E4 reporter in the absence of
cotransfection of Pax6 expression vector was taken as 1. The SRA01/04 cells were used. (F) Very weak effect of Pax6b isoform on LE9. The transactivational
effect of Pax6b on LE9 was compared with that of Pax6. The relative luciferase activity of the basal reporter (pE4luc) without cotransfection of Pax6
expression vector was taken as 1.
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results indicate that Pax6 protein forms a complex with
DNA containing the LE11 sequence. In contrast, when
nuclear extracts containing Pax6b protein were used, we
observed no detectable specific protein–DNA complex (data
not shown). When Pax6 or Pax6b protein synthesized using
a cell-free in vitro translation system was used in the com-
plex formation assay, essentially identical results to those
with nuclear extracts were obtained (data not shown).
When several nonlabeled DNA fragments were exam-
ined in competition assays, LE9 and LE11 sequences com-
peted to a similar degree against the labeled LE11 probe
(Fig. 3C). In a reciprocal experiment using a labeled LE9
Fig. 3. Pax6 protein binds to the distal half of LE9. (A) Sequence similarity of Pax6 paired domain-binding consensus and the LE11 sequence. A schematic
diagram of overlapping LE9, LE10, and LE11 fragments is shown by using open boxes. The sequence of LE11 and the consensus for the Pax6 paired domain
binding sequences (Epstein et al., 1994a) are presented in an alignment. Base substitutions (from M1 to MF) introduced into the LE11 sequence are shown
by white letters on a black background. LE11-MF contains the corresponding sequence from the fugu (pufferfish) Pax6 gene. (B) Complex formation with
LE11 and Pax6 protein. Pax6 protein-containing nuclear extracts were tested with the indicated probes in an electrophoretic mobility shift assay. The arrow
marked “S” indicates a shifted band of the LE11 probe. Similar results were obtained with an LE9 probe (data not shown). The arrow marked “SS” indicates
a supershift band that appeared as a result of coincubation with anti-Pax6 monoclonal antibody. (C) Competition assay for the Pax6–LE11 complex.
Increasing amounts of the indicated DNA fragments (0.04, 0.1, and 0.2  1012 mol) were included as unlabeled competitors with the labeled LE11 probe.
“PRD” indicates the oligonucleotides with an optimal paired-domain binding sequence for Pax6 protein. (D) Competition assay using the mutated LE11
sequences (see A). The indicated individual LE11 mutants (0.1 and 0.2  1012 mol) were examined as competitors to the labeled LE11 probe for binding
to Pax6 protein.
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probe, the LE9 and LE11 fragments again showed similar
competition abilities (data not shown). An “optimal” bind-
ing sequence of the Pax6 paired domain (PRD; Fig. 3C)
exhibited higher competition ability. These data further sup-
port the notion that Pax6 protein, but not Pax6b, can asso-
ciate directly with LE11 via its paired domain.
Close inspection of the sequence of LE11 enabled us to
identify a sequence similar to the consensus recognition se-
quence of the Pax6 paired domain (Fig. 3A). A series of
substitutional mutations in this region (Fig. 3A) were assayed
for their competition ability against the wild-type LE11 probe
in EMSA. As shown in Fig. 3D, mutants M3 and M4 lost
almost all competition ability, whereas M1, M2, and M5
showed various levels of competition ability. Accordingly,
when mutant M2 was used as labeled probe, a weak band was
detected (Fig. 3B). The above results suggest that the distal half
of LE9 (LE11) is the most critical for sequence recognition by
Pax6 protein. The corresponding enhancer region of the fugu
(pufferfish) Pax6 gene differs at several positions from those of
mouse and human Pax6 genes when these regions are aligned
(Fig. 3A). Oligonucleotides with the fugu sequence (LE11-
MF; Fig. 3A) exhibited a high competition ability comparable
to those of LE9 and LE11 (Fig. 3D). Taken together, these
results indicate that mutations in the LE11 sequence impaired
DNA–protein complex formation at various levels, and that
some deviations from the mammalian sequence are tolerated.
This finding also suggests that the interaction of Pax6 protein
with this enhancer site is widely conserved among vertebrates.
Sox2 and Sox3 activate the LE9 enhancer synergistically
with Pax6
The results described in the above sections indicate that
Pax6 protein contributes to the formation of DNA–protein
complexes with LE11 and LE9 in vitro. During the course
of these experiments, we noticed that Sox2 and Sox3 can
activate the head surface ectoderm-specific enhancer of
Pax6 synergistically with Pax6, and the minimal region for
this activation was mapped within LE9. Sox2 and Sox3
proteins are Sry-related HMG domain-containing transcrip-
tion factors and dynamically expressed during lens devel-
opment (Uchikawa et al., 1999; Baker and Bronner-Fraser,
2001). Since Sox2 and Sox3 are known to modulate en-
hancer activities through cooperation with partner transcrip-
tion factors (reviewed in Kamachi et al., 2000), and since
the LE9 sequence has multiple copies of HMG domain
binding motif-like sequences (Denny et al., 1992), we ex-
amined the effects of Sox2 and Sox3 on various fragments
of the ectoderm-specific enhancer of Pax6. In Fig. 4A, we
arbitrarily numbered these three HMG domain binding mo-
tif-like sequences according to their order of proximity to
the Pax6-binding site, which is indicated by an open box.
When coexpressed with Pax6, Sox2 elevated LE9 en-
hancer activity synergistically with Pax6 in RL-34 rat liver
epithelial cells (Fig. 4B). Similar pattern of activation was
observed with other cell lines. Sox2 protein alone resulted in
no significant activation of LE9 or other enhancer frag-
ments. Interestingly, Sox2 coexpression caused a detrimen-
tal effect on the Pax6-dependent activation of PRDx4. The
LE11x4 reporter plasmid also showed decreased activity
when Sox2 was coexpressed. Thus, LE11 resembled PRD
rather than LE9 in terms of the synergistic effect by Pax6
and Sox2. Since LE11 contains the presumed Pax6 binding
sequence, but lacks the HMG domain binding motif-like
sequences, these results suggest that the synergistic activa-
tion by Sox2 is dependent on the HMG domain binding
motif-like sequences within LE9. Sox3 and Pax6 proteins
also exhibited a similar synergistic effect (Fig. 4C).
Sequence requirement for the synergistic activation
To determine which part of the sequence is required for
the synergistic activation, we introduced a series of muta-
tions (Fig. 4A) within the LE9 or LE6 sequence. As ex-
pected from the EMSA (Fig. 3), mutations within the pre-
sumed Pax6-binding site (M1, M2, M3, and M4; Fig. 4A)
severely diminished the synergistic activation by Pax6 and
Sox2 as well as the Pax6-dependent response of the reporter
constructs (Fig. 4D). In contrast, mutations (from M5 to
M11) located outside of the presumed Pax6-binding site did
not affect the ability to show Pax6-dependent activation.
These data clearly demonstrate that the Pax6 recognition
sequence is essential for the activation of LE9 by Pax6 and
for the synergistic activation by Pax6 and Sox2.
Among the mutations outside of the presumed Pax6-
binding site, M6, M7, and M11 prevented the Sox2-depen-
dent activation of the LE9 enhancer (Fig. 4D). Thus, among
the three HMG domain binding motif-like sequences, the
second one was found to be the most important for the
synergistic activation of LE9 by Sox2 and Pax6, although
other sites might contribute weakly.
The above results identify Sox2 and Sox3 as candidate
factors that differentially modify the activity of Pax6 and
indicate that their action is dependent on the presumed HMG
domain-binding motifs in the LE9 sequence. We therefore
performed EMSA using a recombinant Sox2 protein contain-
ing the HMG domain and detected a specifically shifted band
(Fig. 5A). When nonlabeled competitors with the sequence
from the second HMG domain-binding motif (LE15; Fig. 5B)
were included, the wild-type sequence, but not mutant se-
quences, competed well against the LE9 probe (Fig. 5A). LE15
also competed effectively against the DC5 sequence of the
chicken 1-crystallin gene (data not shown), which contains a
functional binding site of the Sox2 HMG domain (Kamachi et
al. 2001). When Pax6 and Sox2 recombinant proteins were
added together with the LE9 probe in EMSA, a supershifted
band was detected (Fig. 5C), indicating that these two proteins
can bind to LE9 simultaneously under these conditions. Taken
together, these results indicate that Sox2 can bind to the prox-
imal half of LE9.
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Complex formation between Pax6 and Sox2 proteins
To examine whether Pax6 protein and Sox2 protein in-
teract physically, we produced Flag-tagged Pax6 and Myc-
tagged Sox2 and performed immunoprecipitation assays
using anti-Flag and anti-Myc monoclonal antibodies. These
two tagged proteins exhibited synergistic activation of LE9
similar to that of untagged Pax6 and Sox2 in reporter assays
(data not shown).
Initially, Flag-Pax6 and/or Myc-Sox2 were expressed
and cellular proteins were immunoprecipitated by using
anti-Myc antibody. The collected immune complex was
Fig. 4. Pax6 protein acts synergistically with Sox2 and Sox3 proteins to activate the LE9 enhancer of the Pax6 gene. (A) Candidate sites for the Sox protein
recognition within the LE9 enhancer sequence. The sequence of LE9 (double stranded) is presented and the positions of overlapping enhancer fragments
(LE9, LE10, and LE11) are schematically indicated by black boxes. The putative Pax6-binding sequence identified in this study is indicated by an open box.
Three HMG-domain binding motif-like sequences (TTGTA or TTGAA) are arbitrarily numbered and marked by arrows indicating the orientation. The LE9
regions of reporter plasmids with mutated enhancer sequences are shown in an alignment. The introduced nucleotide substitutions are indicated by white
letters on black rectangles. (B) Synergistic activation of LE9 by Pax6 and Sox2 proteins. RL-34 cells were transfected with each indicated reporter plasmid
and increasing amounts of the Sox2 expression construct (0, 38, or 75 ng per well of a 12-well plate) in the absence or presence of the Pax6 expression plasmid
(0 or 75 ng). The activity of each reporter alone was taken as 1. LE9 reporter was synergistically activated by Pax6 and Sox2, whereas Sox2 had detrimental
effects on the activation of LE11 and the “optimal” Pax6 binding sequence (LE11x4 and PRDx4, respectively) by Pax6 protein. (C) Synergistic effect of Sox3
and Pax6 protein. Sox3 expression vector and either control vector or the Pax6 expression vector were cotransfected with LE9 reporter plasmid. Sox3 showed
a pattern of synergistic activation similar to that of Sox2. (D) Sequence requirement for the synergistic effects of Pax6 and Sox2. Reporter plasmids with
the mutated enhancers listed in (A) were assayed for transactivation by Pax6 and Sox2 via transfection of 75 ng of each expression plasmid. The activity
of each reporter without the expression plasmids was regarded as 1.
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resolved by SDS–PAGE and subsequently blotted by using
anti-Flag antibody. A specific band for Flag–Pax6 was ob-
served only when Flag–Pax6 and Myc–Sox2 were coex-
pressed (Fig. 5D). In a reciprocal experiment with anti-Flag
antibody immunoprecipitation followed by anti-Myc anti-
body immunoblotting, a specific band for Myc–Sox2 was
Fig. 5. Sox2 forms a complex with LE9, and interacts with Pax6. (A) Complex formation with 32P-labeled LE9 probe and recombinant Sox2 protein
containing the HMG domain (indicated by an arrow). Various amounts of nonlabeled competitors (0.13, 0.66, and 3.3  1012 mol) were included in the
EMSA. (B) Sequences of the competitors used in (A). LE15 contains the second candidate sequence for Sox2 binding. Mutations M6 and M7 correspond
to those used in the reporter assays in Fig. 4. Three HMG domain-binding motif like sequences are marked by arrows. (C) Complex formation of Pax6 and
Sox2 proteins with 32P-labeled LE9. Recombinant Pax6 protein containing the paired domain was included at 0,100 (labeled as x1), or 200 ng/ml (x2).
Recombinant Sox2 protein was added at 0, 40 (x1), or 80 ng/ml (x2). Shifted bands are indicated by arrows. When recombinant Pax6 and Sox2 proteins were
included together, a supershifted band appeared (indicated by “S”). (D) Flag-tagged Pax6 present in the immunoprecipitate for Myc-tagged Sox2. Lysates
from cells transfected with expression vector(s) encoding Flag-tagged Pax6 (F-Pax6), Myc-tagged Sox2 (M-Sox2), or both were incubated with control IgG
or an anti-Myc monoclonal antibody. The collected immune complexes were analyzed by Western blotting using an anti-Flag monoclonal antibody. As
controls, diluted whole cell lysates were also subjected to Western blotting. The sizes of marker proteins in kilodalton (kDa) and their positions are shown
on the right side. (E) Myc–Sox2 present in the immunoprecipitate for Flag-Pax6. In a reciprocal experiment, the cell lysates were immunoprecipitated with
an anti-Flag antibody or control IgG, and then the immune complexes were analyzed by Western blotting using an anti-Myc monoclonal antibody.
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detected (Fig. 5E). Thus, Pax6 and Sox2 proteins can form
a complex under these conditions.
Discussion
In this study, we identified and mapped a Pax6-respon-
sive element (LE9) within the head surface ectoderm-spe-
cific enhancer of the mouse Pax6 gene. Sox2 and Sox3
proteins activated the LE9 reporter construct synergistically
with Pax6. Several lines of evidence suggest that Pax6
protein binds to the distal half of LE9 (LE11) directly via its
paired domain: (1) Pax6b protein was inactive in both the
reporter assay and the EMSA. (2) LE11 has sequence sim-
ilarity to the Pax6 paired domain-binding consensus. (3)
Oligonucleotides with an “optimal” paired domain-binding
sequence of Pax6 competed with this element effectively in
the EMSA. This DNA–protein interaction may be evolu-
tionarily conserved in vertebrates, since the corresponding
region from the pufferfish Pax6 gene showed strong com-
petitive activity with the mouse element in the EMSA.
The recognition sequences of the paired domains of the
Pax family proteins are unusually long (up to 20 bp in
length) and seemingly degenerate. Pax6-binding sites have
been mapped in the regulatory regions of several crystallin
genes, and they deviate from the consensus sequence de-
duced from the PCR-based random oligonucleotide selec-
tion method (Cvekl et al., 1995; Cvekl and Piatigorsky,
1996; Epstein et al., 1994a). Naturally occurring Pax5-
binding sites present in Pax5-target genes deviate at several
positions from the consensus binding sequence of Pax5, and
they usually bind the paired domain of Pax5 with lower
affinities than sequences matching the consensus (Czerny et
al., 1993; Czerny and Busslinger, 1995). These observations
suggest that the high affinities which consensus sequences
possess are not always necessary in vivo (Czerny and
Busslinger, 1995), and that it is very difficult to identify a
Pax-binding element based only on sequence information.
Multiple lines of evidence, such as from reporter assays and
EMSAs, are necessary for identifying an actual target site of
a Pax protein.
Several reports have indicated that Pax6 protein itself is
essential for the maintenance of Pax6 gene expression in the
developing lens in vivo (Grindley et al., 1995; Ashery-
Padan et al., 2000). By conditionally disrupting the Pax6
gene in the presumptive lens ectoderm using the Cre-loxP
system, Ashery-Padan et al. (2000) showed that the head
surface ectoderm-specific enhancer activity in this area is
lost without the presence of Pax6 protein. Together with
detailed analyses of chimeric mouse embryos consisting of
Pax6/ and wild-type cells (Quinn et al., 1996; Collinson
et al., 2000), those reports indicated that Pax6 positively
autoregulates itself during lens development in a cell-auton-
omous fashion. Our findings in the present study suggest
that direct interaction of Pax6 protein with the head surface
ectoderm-specific enhancer contributes to this Pax6 auto-
regulation.
Our results agree well with the in vivo findings discussed
above, but of course do not exclude the possibility of indi-
rect autoregulation of the Pax6 gene expression. Drosophila
genetic analyses have identified eyeless (ey) and twin of
eyeless (toy), both of which are homologues of Pax6, as
well as the sines oculis (so), eyes absent (eya), and dachs-
hund (dac) genetic network in which these genes are inter-
dependently activated (Fig. 6A; reviewed in Treisman,
1999). Since mammalian homologues of the so, eya, and
dac genes have been identified and some of these homo-
logues are known to be expressed in the lens area, Pax6 may
indirectly autoregulate its expression through a similar ge-
netic network. Indeed, this type of regulation may be con-
served in retina development, since the control region of the
Drosophila ey gene has been found to direct reporter gene
expression in the retina of transgenic mice (Xu et al., 1999).
To our knowledge, however, there has been no report show-
ing that the homologues of the so, eya, and dac genes
transactivate the head surface ectoderm-specific enhancer of
the Pax6 gene. In addition to the direct autoregulatory
mechanism proposed here, it will be important to examine
whether an indirect mechanism also mediates another level
of regulation of Pax6 expression and function. The Pax6b
isoform, which plays important roles in eye development
(Singh et al., 2002), might be involved in such regulation,
although this isoform neither binds to nor stimulates the
LE9 enhancer of the Pax6 gene. It is noteworthy that the
direct autoregulation of Pax6 proposed in this study may be
Fig. 6. A model for the Pax6 expression in the lens. (A) The ey/so/ea/dac
genetic network identified by Drosophila genetic analyses (reviewed in
Treisman, 1999). (B) A model for direct autoregulation of the Pax6 gene
in the lens proposed based on this study. In this model, Pax6 protein binds
to the LE9 region in the head surface ectoderm-specific enhancer of the
Pax6 gene, and positively regulates its own expression. Pax6 protein also
interacts with Sox2 and Sox3 proteins to activate LE9 synergistically.
Autoregulation of Pax6 may be homologous to the activation of ey by toy,
the latter of which is closely related to ey.
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homologous to the activation of ey by toy, the latter of
which is closely related to ey and Pax6.
Our results indicated that Sox2 and Sox3 can modify the
transcriptional activity of Pax6 protein differentially in a
sequence-dependent manner. Sox family proteins are
known to modulate enhancer activities through cooperation
with partner transcription factors, and the number of re-
ported partner factors is quite large (reviewed in Kamachi et
al., 2000). Furthermore, a growing number of transcription
factors have been shown to interact with Pax6 or other
members of the Pax family. These include Ets and Pax5 for
synergistic interaction with the binding sequences in the
mb-1 gene promoter region, and Sox10 and Pax3 for the
MITF and c-ret genes (Bondurand et al., 2000; Potterf et al.,
2000; Lang et al., 2000). The synergistic interaction of Pax6
protein with Sox2 or other proteins thus might be involved
in the regulation of a variety of genes. Recently, Kamachi et
al. (2001) reported that Sox2 and Pax6 proteins form a
ternary complex with an enhancer element termed DC5 of
the chicken 1-crystallin gene, resulting in cooperative ac-
tivation of the enhancer fragment. LE9 in the present study
differs from DC5 in several respects: (1) In contrast to DC5,
LE9 is activated substantially by Pax6 alone in reporter
assays; (2) the orientation of the second HMG binding motif
in LE9 relative to the Pax6 binding site is opposite from that
of DC5. Pax6 protein seems to bind to LE9 strongly without
cooperative binding with Sox2, since in EMSA, Pax6-LE9
interaction is detected in the presence of a high concentra-
tion of nonspecific DNA, whereas Pax6–DC5 interaction is
inhibited (data not shown). Thus, Sox2 and Sox3 may affect
the LE9 enhancer activity via other molecular mechanisms,
such as DNA-bending.
We showed here that, in addition to the proposed Pax6-
recognition site, the HMG domain binding motif-like se-
quences in LE9 are essential for the synergistic activation
by Pax6 and Sox2/3. On the other hand, Sox2 and Sox3 had
detrimental effects on the ability of Pax6 to activate the
Pax6-binding sites (LE11 and PRD) lacking the HMG do-
main binding motif-like sequences in reporter assays. Sox2
and Sox3 proteins might recruit Pax6 protein away from the
Pax6-binding sites, since the Sox2 and Pax6 proteins can
form a complex, as indicated by our immunoprecipitation
analyses. It will be interesting to examine whether Sox2 and
Sox3 can negatively modulate the expression levels of Pax6
target genes.
Based on the findings of the present study, we propose a
model for the autoregulation of Pax6 expression in the lens
area, in which Sox2 and Sox3 proteins act as modifiers that
positively and negatively modulate the Pax6 functions in the
genetic cascade of lens development (Fig. 6B). Broad ex-
pression of Pax6 in the head surface ectoderm is detected in
the presumptive lens area earlier than the emergence of the
lens placode, but later its expression becomes more domi-
nant in the lens placode and the lens vesicle. The levels of
expression of Sox2 and Sox3 are highly upregulated in the
emerging lens placode and also in other sensory placodes
(reviewed in Baker and Bronner-Fraser, 2001). Therefore,
Pax6 protein may directly contribute to the autoregulation
of the Pax6 gene in the developing lens, whereas Sox2 and
Sox3 proteins may be involved in regulating the expression
of Pax6 and other genes during and after the placode stage
of lens development, as illustrated in Fig. 6B.
In our model, Sox2 and Sox3 are placed in the direct
upstream position of Pax6 gene expression. This model is
consistent with the results of an in vivo study in which Sox3
was overexpressed in medaka fish embryos (Ko¨ster et al.,
2000). Those experiments revealed that ectopic Sox3 ex-
pression leads to ectopic expression of endogenous Pax6
and Eya1 (a homologue of the Drosophila eyes absent gene
that is expressed in the otic placode and vesicle) genes in the
embryonic ectoderm and causes formation of ectopic lens
tissues and otic vesicles, respectively. Those authors ob-
served spatial restriction of gene activation: ectopic Pax6
expression and subsequent formation of ectopic lenses ex-
clusively in the ventrolateral head ectoderm, which overlaps
with the region known to have competence or bias for lens
placode formation (Grainger, 1992), and ectopic Eya1 ex-
pression in the posterior and dorsal head- and trunk-ecto-
derm. Our model can explain how ectopic Sox3 expression
activates ectopic Pax6 expression in a regionally restricted
manner, i.e., due to the requirement for preceding Pax6
expression.
Pax6 is expressed in several tissues in addition to the
lens, such as the retina, the neural tube, and the pancreas.
Sox2 or Sox3 expression overlaps with Pax6 expression in
the lens and several other tissues, most notably in the retina
and the neural tube (Baker and Bronner-Fraser, 2001). Al-
though it is unclear at present why the head surface ecto-
derm-specific enhancer of the mouse Pax6 gene is inactive
in these tissues other than the lens, one possible explanation
is that the enhancer region contains negative regulatory
elements that suppress the proposed positive feedback loop
in these tissues. It is noteworthy that we observed negative
effects of the region outside of LE9 in the reporter assays
(Figs. 1 and 2). Kammandel et al. (1999) reported ectopic
expression of the lacZ reporter in the retina when some parts
(outside of LE0 in Fig. 1) of the enhancer region were
deleted in the transgenic mouse study. Those authors there-
fore postulated the presence of negative regulatory elements
outside of LE0. Furthermore, Plaza et al. (1999) reported
that their reporter constructs carrying parts of the “B frag-
ment” of the quail Pax6 gene enhancer region, which cor-
responds to the head surface ectoderm-specific enhancer of
mouse, are active in the reporter assays using cultured
embryonic neuroretina cells. Interestingly, their shortest
fragment (corresponding approximately to LE2 in this re-
port) showed a higher activity than other longer enhancer
constructs. These findings support the notion that negative
regulatory mechanisms also play important roles in the
tissue specificity of the head surface ectoderm-specific en-
hancer of the Pax6 gene.
The level of Pax6 expression in the lens area is crucial
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for lens development, and the mechanisms regulating this
expression are considered to be complex and multistep. Our
results will provide important clues to understanding the
molecular mechanisms of lens development.
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